ADAG
$2.00
Adagene Inc ADR
ADAG
Earnings Whisper ®
N/A
1st Quarter March 2022
Consensus:  ($0.53)
Revenue:  N/A
Thursday
Mar 31
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ADAG reports earnings?
Beat
Meet
Miss

Where is ADAG's stock price going from here?
Up
Flat
Down
Stock chart of ADAG
Analysts
Summary of analysts' recommendations for ADAG
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene Inc. is based in SAN FRANCISCO, Calif.